Net loss widened significantly to $14.4M from $5.6M year-over-year.
Gross margins slipped from 14.7% to 14.1% due to weather and depreciation.
Upcoming Neogenyx JV to inject $400M of institutional capital.
Refinanced term loan and revolving credit facility in early 2025.
The Q1 2026 filing reveals a company at a critical crossroads, balancing aggressive growth and a massive project pipeline against a backdrop of widening net losses and high leverage. The surge in revenues and the scale of the backlog indicate a strong market demand for energy transition infrastructure, yet the inability to translate this top-line growth into GAAP profitability highlights a struggle with operating leverage and rising financing costs. The ultimate trajectory for investors depends on the execution of the Neogenyx Fuels joint venture and the conversion of awarded projects into signed contracts. If Ameresco can successfully monetize its biogas assets and stabilize its margins, the current losses may be viewed as a temporary cost of scaling. However, the reliance on opaque variable-interest entity structures and the volatility of working capital suggest that the path to sustainable profitability remains fraught with financial risk.